XML 38 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2019
Stockholders' Equity  
Schedule of employee service share-based compensation, allocation of recognized period costs

Stock-based compensation cost that has been expensed in the statements of operations amounted to $58,000 and $244,000, respectively, for the three months ended September 30, 2019 and 2018 and $781,000 and $1.1 million, respectively, for the nine months ended September 30, 2019 and 2018, is allocated as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30, 

 

September 30, 

 

    

2019

    

2018

    

2019

    

2018

Research and development

 

$

27,072

 

$

151,580

 

$

313,247

 

$

451,662

General and administrative

 

 

31,041

 

 

91,956

 

 

468,143

 

 

673,308

 

 

$

58,113

 

$

243,536

 

$

781,390

 

$

1,124,970

 

Schedule of key assumption of fair value of stock options granted

Key assumptions used in the determination of the fair value of stock options granted are as follows:

 

 

 

 

 

 

 

 

 

 

 

    

2019

    

2018

Expected term

 

5.67

 

years

 

5.50

 

years

Risk-free interest rate

 

1.82

%  

  

 

2.72

%  

  

Expected dividend yield

 

 —

 

  

 

 —

 

  

Expected volatility

 

80.38

%  

  

 

77.29

%  

  

 

Schedule of stock options roll forward

A summary of stock option activity is as follows:

 

 

 

 

 

 

 

 

 

Outstanding stock options

 

 

Number of

 

Weighted average

 

    

shares

    

exercise price

Balance at December 31, 2018

 

2,424,617

 

$

5.00

Options granted

 

79,000

 

 

1.84

Options exercised

 

(20,000)

 

 

2.81

Options forfeited

 

(21,221)

 

 

2.17

Options cancelled

 

(151,911)

 

 

6.93

Balance at September 30, 2019

 

2,310,485

 

 

4.81

 

 

 

 

 

 

Options exercisable at September 30, 2019

 

1,752,657

 

 

5.69

 

Schedule of share-based compensation of stock options outstanding and exercisable

The following table summarizes information about stock options outstanding and exercisable at September 30, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding

 

Options exercisable

 

 

Weighted

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

remaining

 

Weighted

 

 

 

 

 

 

remaining

 

Weighted

 

 

 

 

 

contractual

 

average

 

Aggregate

 

 

 

contractual

 

average

 

Aggregate

Number

 

life

 

exercise

 

intrinsic

 

Number

 

life

 

exercise

 

intrinsic

outstanding

    

(Years)

    

price

    

value

    

exerciseable

    

(Years)

    

price

    

value

2,310,485

 

6.29

 

$

4.81

 

$

747,653

 

1,752,657

 

5.45

 

$

5.69

 

$

181,143

 

Schedule of nonvested restricted stock units activity

A summary of restricted stock unit activity is as follows:

 

 

 

 

 

 

Number of

 

 

unvested restricted

 

    

shares

Balance at December 31, 2017

 

682,124

Granted

 

50,000

Vested

 

 —

Cancelled

 

(53,437)

Balance at September 30, 2018

 

678,687